Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
M. E. Christine Lutsiak(National Institute of Allergy and Infectious Diseases), Helen Sabzevari(National Institute of Allergy and Infectious Diseases), S. V. S. Kashmiri(National Institute of Allergy and Infectious Diseases), Roberto De Pascalis(National Institute of Allergy and Infectious Diseases), Jeffrey Schlom(National Cancer Institute), Roshanak Tolouei Semnani(National Institute of Allergy and Infectious Diseases)
Cited by 896
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973
Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors
|Hybridoma|1984|580
A spectrum of monoclonal antibodies reactive with human mammary tumor cells.
|Proceedings of the National Academy of Sciences|1981|563